Merck asks FDA for emergency approval of its new antiviral pill for COVID
Robin Foster, HealthDay reporter FRIDAY, October 1, 2021 (HealthDay News) – Pharmaceutical giant Merck & Co. said Friday it will apply for state approval for the emergency use of its new antiviral pill, molnupiravir, after a clinical study showed the drug’s risk…Read More »
